Blood Pressure in Scleroderma Renal Crisis
Scleroderma renal crisis typically presents with severe hypertension, with blood pressures commonly exceeding 140/90 mmHg and often reaching markedly elevated levels (e.g., 180-240/100-145 mmHg), though importantly, normotensive SRC can occur in approximately 20-30% of cases.
Typical Blood Pressure Patterns
Hypertensive SRC (Most Common - ~78% of cases)
The majority of SRC patients present with pronounced hypertension 1:
- Blood pressures frequently range from 180/100 to 240/145 mmHg at presentation 2, 3
- One case series documented a patient with BP of 214/105 mmHg 3
- Another reported 230/120 mmHg with malignant hypertension 4
- The defining threshold is BP >140/90 mmHg in the context of acute kidney injury and SSc 5
Normotensive SRC (Uncommon but Critical - ~20-30% of cases)
A critical pitfall is missing normotensive SRC, which carries worse prognosis 5, 1:
- Blood pressure remains <140/90 mmHg despite acute kidney injury and thrombotic microangiopathy
- Strongly associated with high-dose corticosteroid use (≥30 mg/day prednisone in 64% of normotensive cases vs 16% of hypertensive cases) 5
- More difficult to diagnose promptly, leading to delayed treatment
- Can occur even in transplanted kidneys 6
Clinical Context and Monitoring
Key Diagnostic Features Beyond Blood Pressure
When evaluating for SRC, look for the constellation of:
- Acute kidney injury (rising creatinine, often peaking 5-14 days post-onset) 7
- Thrombotic microangiopathy (thrombocytopenia, hemolytic anemia, elevated LDH, schistocytes) 3, 1
- Hypertensive complications when BP elevated: encephalopathy (58%), headache, seizures 2, 1
- Proteinuria 3
Important Caveats
Pseudohypertension can occur in diffuse scleroderma due to noncompressible vessels from skin thickening 8. If sphygmomanometry shows extreme elevations (e.g., 240/135 mmHg) but clinical picture doesn't match, consider intra-arterial monitoring to avoid inappropriate treatment escalation.
Risk Factors for Development
Patients at highest risk for SRC include 7:
- Male sex (OR 9.73)
- Diffuse cutaneous disease (OR 23.16)
- Anti-Scl70 antibodies (OR 3.34) or anti-RNA polymerase III antibodies (OR 5.15)
- Corticosteroid exposure, particularly ≥15 mg/day prednisone 5, 1
- Early disease (median 2 years from SSc diagnosis) 7
Monitoring Recommendations
For patients with SSc on corticosteroids, blood pressure and renal function must be monitored carefully 5. The 2017 EULAR guidelines explicitly state this monitoring imperative given the strong association between glucocorticoid use and SRC development (36% of SRC patients received prednisone ≥15 mg/day within 6 months preceding SRC vs 12% of controls, OR 4.4) 5.
Do not rely solely on elevated BP to diagnose SRC—maintain high suspicion in any SSc patient with acute kidney injury, particularly those on corticosteroids, even if normotensive.